Long-Term Type 1 Diabetes Enhances In-Stent Restenosis after Aortic Stenting in Diabetes-Prone BB Rats

Table 1

Characteristics of the diabetic (DM) and thymectomized non-diabetic (non-DM) BBDP rats that were stented and evaluated for the development of in-stent restenosis.

	N	Gender; ♀/♂	Diabetes onset; (median in days)	Age at stenting; (median in days)	Diabetes duration at stenting; (median in days)	Serum creatinine^a; (mean ± SEM in μmol/L)
Non-DM BBDP	6	4/2	N.A.^b	298 [270–412]^c	N.A.^b	51 ± 7
DM BBDP	7	3/4	82 [72–140]^c	270 [270–290]^c	198 [150–204]^c	56 ± 9

^aSerum creatinine levels were determined 2 weeks prior to stenting.
^bN.A.: not applicable.
^cValues between brackets indicate minimum and maximum values.